Ethymed

Ethypharm is a leading European specialty pharmaceutical company focused on Central Nervous System (CNS) diseases and Hospital Care. The company specializes in the development and commercialization of treatments for pain, addiction, and critical care, leveraging its expertise in complex formulation and drug delivery technologies. Ethypharm maintains a strong presence in Europe, particularly in France, the UK, and Germany, while expanding its reach globally through a network of partners. Its portfolio includes established brands and innovative digital therapeutics designed to improve patient outcomes in chronic and acute settings.